New imaging trick could sharpen cancer scans
NCT ID NCT07009184
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new imaging agent (TGW211) in 19 adults with HER2-positive solid tumors. The goal is to see if a special 'trigger' can help clear the imaging tracer from healthy tissues faster, making tumor scans clearer. The study focuses on safety and image quality, not treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE SOLID TUMOR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Radboud University Medical Center
RECRUITINGNijmegen, Gelderland, 6525 GS, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.